Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Hepatitis C treatment
Lack of health insurance limits hepatitis C patients' access to latest antiviral therapy

New research has determined that patients in the U.S. with hepatitis C virus are twice as likely to not have health insurance coverage compared with those without the disease. Details of this study are published in the March issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases.

Published
24 February 2011
From
Eurekalert Inf Dis
Hepatitis C symptoms and diagnosis
OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood

The OraQuick HCV Rapid Antibody Test is the only rapid, point-of-care test for the detection of antibodies to the hepatitis C virus that is approved by the FDA. The test, which utilizes the OraQuick® technology platform, provides results in 20 minutes.

Published
22 February 2011
From
Stock Markets Review
Hepatitis C treatment
Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus

The Swedish company Medivir today announced further positive results from the phase 2b PILLAR study of TMC435 in treatment-naive patients with HCV genotype 1.

Published
22 February 2011
From
PR Newswire
Hepatitis C treatment
Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 In Adults With Chronic Genotype 1 HCV

Tibotec Pharmaceuticals announced that two global, registrational phase 3 trials are recruiting patients to examine TMC435, its investigational hepatitis C protease inhibitor, in treatment-naïve adults with chronic genotype 1 hepatitis C virus (HCV). A third global phase 3 trial is being conducted in genotype 1 HCV patients who have experienced a viral relapse after prior interferon-based treatment.

Published
22 February 2011
From
Medical News Today
Cancer
Nanotechnology may lead to new treatment of liver cancer

Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death in test tubes and mice.

Published
22 February 2011
From
Eurekalert Medicine & Health
Hepatitis C transmission and prevention
U.S. hepatitis C cases down sharply since 1980s

New infections of the liver with hepatitis C virus are far less common these days in the U.S. compared to the early 1980s, a new government study finds.

Published
16 February 2011
From
Reuters
Pharmaceutical industry
Idenix drops after FDA loosens one hold but slaps on another

Just as regulators decided to change a full clinical hold on Idenix's lead hepatitis C drug to a partial hold, paving the way to a combo drug trial later this year, the FDA slapped a new clinical hold on an HIV therapy the biotech had licensed to GlaxoSmithKline, jeopardizing $390 million in milestones.

Published
10 February 2011
From
Fierce Biotech
Hepatitis C symptoms and diagnosis
Vertex urges CDC to recommend hep C screening, to nudge `second tsunami` of patients

If Vertex Pharmaceuticals gets its way in talks with U.S. public health officials, most people over 50 could soon get blood tests to screen for hepatitis C infections at the doctor’s office.

Published
03 February 2011
From
EATG
Hepatitis C transmission and prevention
Incidence Of Hepatitis C Infection In HIV-Infected Men in the United States

"Screening HIV-infected patients for hepatitis C only once upon entry into HIV care is not sufficient," according to study author Lynn E. Taylor. HIV-infected persons should have access to ongoing screening for hepatitis C."

Published
03 February 2011
From
HIV / AIDS News From Medical News Today
Hepatitis C transmission and prevention
Infectious Disease Experts Call for More Focus on Hepatitis C - U.S. News & World Report

Among injection drug users, new cases of HIV infection have declined dramatically in the past two decades, but the number of new infections from the hepatitis C virus have dropped only a small amount, a new study reports.

Published
01 February 2011
From
Google Alerts HIV
← Prev1...149150151152153...155Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.